广

Andrew A Bolinger1, Jun Li1, Xuping Xie2,3

  • 1Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA.

概括

开发广泛的抗病毒药物对于对抗高致病性冠状病毒 (CoV),如SARS-CoV,MERS-CoV和SARS-CoV-2至关重要. 这种方法增强了对未来病毒威胁的公共卫生弹性.